drugset / Trial / NCT01995526
A Study of Insulin Peglispro in Healthy Male Japanese Participants
NaSingle-groupOpen-labelBasic science
Summary
The main purpose of this study is to evaluate how the body processes the study drug known as insulin peglispro and how the study drug affects blood sugar in healthy male Japanese participants. This study will also evaluate safety of the study drug. The study will last up to 46 days for each participant, not including screening.
Timeline
- Start
- 2013-12
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin Peglispro | Protein / enzyme biologic | 1.3 iu/kg | Subcutaneous |
Indications
No indication recorded.